Apex Biotechnology Corp (1733):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Apex Biotechnology Corp (1733) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6438
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Apex Biotechnology Corp (ApexBio) is a medical device company that develops, manufactures and commercializes biosensor-based blood glucose monitoring systems. The company provides patient self-testing products, point of care diagnostics and multi-functional products. It also imports and exports related products, parts and components. ApexBio’s products include glucose monitoring systems, uric acid monitoring systems, lactate monitoring system, hemoglobin monitoring system, cholesterol monitoring system, hemoglobin A1C POC system, pesticide residue quick check systems and care management and tele-health. The company operates through its manufacturing facilities in Hsinchu City and Taoyuan City in Taiwan. ApexBio is headquartered in Hsinchu, Taiwan.

Apex Biotechnology Corp (1733) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Apex Biotechnology Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Apex Biotechnology Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Apex Biotechnology Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Apex Biotechnology Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Apex Biotechnology Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Apex Biotechnology Corp, Medical Equipment, Deal Details 10
Equity Offering 10
Apex Biotechnology Announces Public Offering Of Shares For US$6.5 Million 10
Debt Offering 11
Apex Biotech Raises USD12.8 Million in Public Offering of Bonds Due 2018 11
Acquisition 12
Apex Biotechnology Acquires 25% Stake In Omnis Health For US$10 Million 12
Apex Biotechnology Corp – Key Competitors 13
Apex Biotechnology Corp – Key Employees 14
Apex Biotechnology Corp – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Apex Biotechnology Corp, Medical Equipment, Key Facts, 2017 2
Apex Biotechnology Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Apex Biotechnology Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Apex Biotechnology Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Apex Biotechnology Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Apex Biotechnology Corp, Deals By Market, 2012 to YTD 2018 8
Apex Biotechnology Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Apex Biotechnology Announces Public Offering Of Shares For US$6.5 Million 10
Apex Biotech Raises USD12.8 Million in Public Offering of Bonds Due 2018 11
Apex Biotechnology Acquires 25% Stake In Omnis Health For US$10 Million 12
Apex Biotechnology Corp, Key Competitors 13
Apex Biotechnology Corp, Key Employees 14
Apex Biotechnology Corp, Other Locations 15

List of Figures
Apex Biotechnology Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Apex Biotechnology Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Apex Biotechnology Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Apex Biotechnology Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Apex Biotechnology Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Apex Biotechnology Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Apex Biotechnology Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Apex Biotechnology Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Apex Biotechnology Corp (1733):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fluxion Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Fluxion Biosciences Inc (Fluxion) is a provider of analytical instruments for functional cellular analyses. The company’s liquid biopsy technologies include IsoFlux CTC liquid biopsy system, ERASE-Seq variant caller for liquid biopsies and the Spotlight 59 for ultra-sensitive NGS mutation de …
  • Bloomin’ Brands Inc:企業の戦略・SWOT・財務分析
    Bloomin' Brands Inc - Strategy, SWOT and Corporate Finance Report Summary Bloomin' Brands Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Albemarle Corporation:戦略・SWOT・企業財務分析
    Albemarle Corporation - Strategy, SWOT and Corporate Finance Report Summary Albemarle Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • BrainScope Company Inc:医療機器:M&Aディール及び事業提携情報
    Summary BrainScope Company Inc (BrainScope) is a medical device company that offers medical neurotechnology products. The company develops and distributes non-invasive instruments for the treatment of traumatic brain injuries, moderate traumatic brain injury and mild traumatic brain injury. It provi …
  • DLF Ltd:企業の戦略・SWOT・財務分析
    DLF Ltd - Strategy, SWOT and Corporate Finance Report Summary DLF Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • BioLineRx Ltd (BLRX):医療機器:M&Aディール及び事業提携情報
    Summary BioLineRx Ltd (BioLineRx) is a clinical stage biopharmaceutical company that focuses on the identification, in-licensing, and development of products to address unmet medical needs. The company focuses mainly on cancer and immunology. Its’s product pipeline includes BL-8040, a short peptide …
  • Valio Ltd:企業の戦略的SWOT分析
    Valio Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Frontera Energy Corp (FEC):企業の財務・戦略的SWOT分析
    Frontera Energy Corp (FEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Altimmune UK Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Altimmune UK Ltd (Altimmune), formerly Vaxin UK Limited, a subsidiary of Altimmune Inc, is a clinical stage immunotherapeutic biotechnology company that develops synthetic vaccines for mutating viruses. The company designs and develops immunotherapeutic products tailored to address a wide ra …
  • Li Ning Company Ltd (2331)
    Li Ning Company Ltd (2331) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Posco International Corp (047050):企業の財務・戦略的SWOT分析
    Posco International Corp (047050) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Lipocine Inc (LPCN):製薬・医療:M&Aディール及び事業提携情報
    Summary Lipocine Inc (Lipocine) is a pharmaceutical company that develops and commercializes treatment for men's and women's health. The company’s pipeline products for men’s health include LPCN 1111 and LPCN 1021; and for women’s health include LPCN 1107. Its LPCN 1111 is an oral testosterone produ …
  • BerGenBio ASA (BGBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary BerGenBio ASA (BerGenBio) is a clinical-stage biopharmaceutical company that develops drugs to treat multiple aggressive cancers. The company develops epithelial-mesenchymal transition inhibitors for acquired cancer drug-resistance and metastasis. Its BGB324 is an AXL kinase inhibitor which …
  • Kolorfusion International Inc:企業の戦略的SWOT分析
    Kolorfusion International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • AVANGRID, Inc.:企業の戦略・SWOT・財務分析
    AVANGRID, Inc. - Strategy, SWOT and Corporate Finance Report Summary AVANGRID, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • UPL Ltd (UPL):企業の財務・戦略的SWOT分析
    UPL Ltd (UPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • MallInckrodt Plc (MNK)-医療機器分野:企業M&A・提携分析
    Summary Mallinckrodt Plc (Mallinckrodt) is a healthcare products provider that offers generics and active pharmaceutical ingredients. The company offers generic products which include addiction treatment products, compounding powders, unit dose products and resource tool kits. Its active pharmaceuti …
  • Plus Therapeutics Inc (PSTV):企業の財務・戦略的SWOT分析
    Plus Therapeutics Inc (PSTV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Arab African International Bank:企業の戦略・SWOT・財務情報
    Arab African International Bank - Strategy, SWOT and Corporate Finance Report Summary Arab African International Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Magnitogorsk Metallurgicheskiy Kombinat:企業の戦略・SWOT・財務情報
    Magnitogorsk Metallurgicheskiy Kombinat - Strategy, SWOT and Corporate Finance Report Summary Magnitogorsk Metallurgicheskiy Kombinat - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆